Record Organic Visit Growth
LifeStance achieved remarkable organic visit growth of 17%, driven by record organic clinician net adds and clinician productivity improvements.
Adjusted EBITDA Growth
LifeStance reported an adjusted EBITDA of $40 million, reflecting a 31% year-over-year increase, with margins reaching 11%, the highest since going public in 2021.
Clinician Expansion
The company added a record 288 organic clinicians, an 11% increase year-over-year, bringing the total to approximately 8,000 clinicians.
Revenue and Visit Volume Increase
Revenue grew 16% year-over-year to $364 million, with visit volumes increasing 17% year-over-year.
Strong Cash Position
LifeStance ended the quarter with a strong cash position of $204 million, doubling from last year, with free cash flow remaining solid at $17 million.
Partnership with Calm
LifeStance announced a partnership with Calm, expanding access to mental health care through seamless referrals for higher acuity care.